
Trapped at sea, fighting at home: COVID-19's toll on northern Ontario 5 years later
Trudy Clement and her husband were among the first Canadians caught in the COVID-19 pandemic when their cruise ship became an unexpected quarantine zone in Japan.
It was early February, 2020, and the couple from Callander, Ont., boarded their vessel with only a vague awareness of an emerging virus.
Soon, the pair alongside approximately 3,700 other passengers, would be confined to their cabin for two weeks.
"We just looked at each other, my husband and I, and it was like, 'You're kidding. You're really kidding me right now,'" Clement said in a 2020 interview.
The ordeal stretched to nearly a month before the couple finally returned home to northern Ontario.
"2020 was a horrible year," Clement told CBC's Morning North on Monday.
Just days after returning from the cruise ship quarantine, Clement's brother died, marking the beginning of a difficult year.
A few months later, her husband Steve passed away from cancer and restrictions prevented typical funeral proceedings.
"A lot of people couldn't pay their respects, other than online or by card," she said.
Follow Trudy as she disembarks from the Diamond Princess
5 years ago
Duration 1:30
Five years later, Clement said she feels like the pandemic taught her to cherish time with family and friends.
"If it's going to teach you anything, it's going to teach you to grow closer together, not grow apart. You don't want to be fighting with anybody during a stressful time like that," she said.
Crisis in Kashechewan
In the summer of 2021, more than a year after Clement's quarantine, one of the worst COVID-19 outbreaks in northeastern Ontario hit the fly-in Cree community of Kashechewan. More than 200 people in the James Bay First Nation of 1,800 were infected.
Several were airlifted to hospitals in southern Ontario – including the elderly parents of Celina Wynne, a frontline mental health worker.
"Mental health was rising, and a lot of anxiety, a lot of everything, because people were scared," she said.
Wynne explained that mental health services had to adapt to COVID-19 restrictions. Counselors began making house visits and sessions took place outside or through a window.
While she was caring for members in the community, her father was fighting for his life in an intensive care unit almost 1,000 kilometres away in Kingston, Ont.
"He said it was like somebody sitting on his chest because he couldn't breathe," Wynne said.
Her mother, who also tested positive, was transported to the same hospital in stable condition.
"My mom was emotional, because she knew my dad was sick, really sick. She thought she wouldn't see him again," Wynne recalled.
Her father eventually returned home and came off the airplane using a walker.
"When he came home, it was sad to see because the strongest man I knew couldn't really walk," she said.
Wynne said her father was encouraged to return to his hobby of making bird decoys out of tamarack, a traditional medicine often used for breathing problems.
"And probably within a week, he was up and walking. He was feeling better. I believe in our medicines and that our traditional medicine helped a lot of people during COVID."
While stories like Clement's and Wynne's unfolded in different ways across the country, healthcare workers and researchers faced a time of uncertainty, urgent decision-making and lessons still being processed.
Dr. Fahad Razak, an internist at St. Michael's Hospital in Toronto and former scientific director of Ontario's COVID-19 science advisory table, remembers the fear and chaos of the early months.
Razak had been working at a hospital where a healthcare worker had previously died from SARS, which he said contributed to the overall sense of unease.
"There was a lot of institutional memory and fear of what could happen when something highly infectious and potentially lethal suddenly emerges," he said.
At the start of the COVID pandemic, many healthcare workers isolated themselves in apartments or hotels to avoid exposing their households.
"They were worried about taking the virus home and exposing young children or older parents," Razak said.
He also recalls patients who died alone due to hospital restrictions.
Calls for formal review of COVID-19 response
The science advisory table, composed of volunteers, was initially expected to only last six months, but as the pandemic intensified, they began meeting 10 to 20 hours a week to analyze rapidly emerging research and provide recommendations.
"You would prepare what you thought was the best possible recommendation based on science, and a new paper could literally come out that afternoon or the following morning, that would change the way you would think," Razak said.
Now, five years later, he believes Canada still hasn't fully processed what happened. Unlike after the 2003 SARS outbreak, which led to a formal review, there has been no equivalent report on COVID-19.
"At a national level and at a provincial level, we have not done a systematic review of the pandemic to learn those lessons the way that we did after SARS one," Razak said.
While Canada has seen improvements in pandemic preparedness – particularly with advancements in vaccine development – Razak remains concerned about lingering weaknesses in the system.
The pandemic left behind widespread staffing shortages, with many frontline workers retiring or leaving the field due to burnout. Without meaningful efforts to rebuild and support the health workforce, Razak fears the system will be even more vulnerable when the next pandemic arrives.
"Almost every scientist that I speak to suspects that the pressures that created this pandemic, which is the very close interface between humans and animals, will create another pandemic situation for the world," he said.
"So it's a question of when that will occur. And I would say the data suggests that even now, there are worrying candidates."

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Japan Forward
3 hours ago
- Japan Forward
AI Tool 'KIBIT': A Game Changer in New Drug Development
このページを 日本語 で読む The COVID-19 pandemic reminded the world of the importance of drug discovery. However, modern drug discoveries require massive financial investment. Meanwhile, the use of artificial intelligence for AI drug discovery is gaining attention as a way to control soaring pharmaceutical prices. And a Japanese-made AI tool named 'KIBIT' is about to open up a new stage in this field. President Donald Trump issued executive orders in April and May mandating the reduction of domestic drug prices in the United States. Accompanying White House fact sheets refer to the high cost Americans pay for prescriptions, which is 2.78 times higher than the OECD average. Prescription costs are also 3.47 times higher than in Japan. Trump sees these high costs to consumers as a serious issue. In Japan, a national drug pricing system sets medication prices, enabling access to affordable treatments due to governmental oversight. In contrast, US pharmaceutical companies can set prices freely. This often results in higher charges than in other countries. Following his May 12 executive order, Trump stated that his orders would cut prices by 59% to as much as 90% to align with the levels of other countries. This could potentially result in significant revenue losses for the pharmaceutical industry. In the case of Japan, major pharmaceutical companies such as Takeda Pharmaceutical Company Limited and Astellas Pharma Inc earn over 30% of their revenue from the US. According to his comments, the President could impose additional tariffs on foreign-manufactured drugs if prices are not reduced. In the search for new drugs and treatments (Screenshot, ©FRONTEO Inc) One major reason for rising drug prices is the increasing cost of research and development. The average R&D spending by Japanese pharmaceutical companies rose from ¥30.2 billion JPY ($298.7 million USD) in 1993 to 163.3 billion ($1.13 billion) in 2019 — a 5.4-fold increase over 26 years. US companies saw an even sharper rise, from $841 million (¥121.1 billion) to $7.449 billion (¥1.0725 trillion). That marked an 8.8-fold increase. Moreover, investing in R&D doesn't guarantee success. The probability of developing a successful drug in Japan dropped from 1 in 13,000 two decades ago to 1 in 23,000 recently. Despite the increasing costs, results are scarce. Consequently, the R&D-to-revenue ratio rose from about 10% in 1993 to around 18% in 2019 in both countries. Introducing KIBIT. (Screenshot ©FRONTEO Inc) AI is being eyed as a solution to reduce R&D costs by dramatically cutting time and expenses. Drug development involves four stages: Basic research & target identification Compound optimization Preclinical trials and Clinical trials. Many AI vendors are involved in drug discovery. In particular, they focus on reducing costs in the third (preclinical) and fourth (clinical) stages. However, most companies have yet to tackle the critical first stage — target identification. Introducing KIBIT. (Screenshot, ©FRONTEO Inc) The first enterprise to address this initial stage is the Japanese company FRONTEO. Utilizing its proprietary natural language processing AI engine KIBIT, the company analyzes vast medical and pharmaceutical literature to generate innovative drug ideas that researchers may not have considered. Human thinking is inherently biased. The more experienced a researcher is, the more difficult it becomes to identify novel molecular targets. Stated another way, the bias of experience often blocks new ideas. KIBIT, however, is free from such biases. It identifies new molecular targets that might be effective against specific diseases. To do so, it analyzes vast amounts of academic literature. It can even derive specific hypotheses. Furthermore, KIBIT can identify and suggest highly disease-relevant target molecules that are not explicitly mentioned in the literature. This significantly enhances drug discovery potential. How KIBIT works. (Screenshot, ©FRONTEO Inc) Only a few countries have the capacity to develop new drugs. In 2024, among newly approved pharmaceuticals in Japan, the US, and Europe, the US led with 143 products. Japan followed with just 12, roughly equal to the United Kingdom's 10. According to the statistics "Nationalities of companies creating the top 100 drugs in the world by sales (2022),": United States – 52 United Kingdom – 10 Switzerland – 9 Germany – 8 Denmark – 8 Japan – 7 Most countries, other than the US, struggle to produce blockbuster drugs. In this context, hopes are high for FRONTEO's KIBIT. If it can consistently generate innovative new drugs efficiently, it may help deliver affordable medicines to those in need, without Mr Trump's intervention. FRONTEO's AI drug discovery service, utilizing KIBIT, is already being adopted by several major pharmaceutical companies. Those leveraging KIBIT to create new drugs could become game changers in the industry. This article is contributed by FRONTEO Inc, a supporting member of JAPAN Forward. (Read the report in Japanese.) Author: FRONTEO Inc. このページを 日本語 で読む

20 hours ago
Dentists praise Canadian Dental Care program, but also express concern over influx of new patients
A northern Ontario dentist says the Canadian Dental Care Plan has generally been positive, but he worries it could cause issues meeting higher demand for dental care over the long term. In June, eligible Canadians between the ages of 18 and 64 can start receiving dental coverage under the plan. Dr. Thomas Detert, a dental surgeon based in Blind River, said the dental plan is bringing in patients who haven't been to a dentist's office in years. Some of them are like over 10 or 15 years because when they retired, they lost their benefits, he said. In some cases, Detert said those patients had good oral hygiene habits and didn't need significant dental care. But in other cases, they put off going to the dentist until they were in serious pain, and needed significant work. While the program has benefited those people, Detert said there's a risk demand for dental care could outstrip the ability of dentists and other oral health professionals to meet it. Much like our socialized medicine in Canada, without proper prevention and education, the demand [has] outstripped any amount of supply that can be thrown at it. And that's what I'm afraid of for socialized dentistry, he said. Around 3.6 million Canadians have been approved by the Canadian Dental Care Plan and around 1.9 million people received care through the plan, as of April. Dr. Jerry Smith, a dentist from Thunder Bay, Ont., and the past president of the Ontario Dental Association, said another 4.5 million Canadians could qualify for the plan with the cohort of people between the ages of 18 and 64. Smith agreed the plan has been positive for people who might not be able to afford dental care otherwise. But he worries a shortage of dental hygienists and assistants will make it challenging for dentists to properly serve an influx of new patients. In Ontario alone, there is a shortage of about 3,400 dental assistants and about 5,500 dental hygienists, he said, quoting figures from a 2022 analysis conducted by the Ontario Dental Association. The Canadian Dental Association estimates that with the increase in patients from the Canadian Dental Care Plan, Canada will need an additional 2,300 dental assistants and over 1,500 dental hygienists in 2025. The numbers from the Ontario Dental Association reference its estimates for the total shortage in the province. In a statement to CBC News Marg Harrington, the CEO of the Ontario Dental Hygienists' Association, said that while some dental practices might struggle attracting dental hygienists, the narrative of a provincewide shortage is inaccurate. The fact is there are more dental hygienists in Ontario than ever before, Harrington said. Registration data from the College of Dental Hygienists of Ontario show a steady increase over the past few years in the number of dental hygienists registered in Ontario. Harrington said that research published last month in the BMC Oral Health journal showed that Ontario had 97 registered dental hygienists per 100,000 population in 2023, which is substantially higher than other provinces. Jonathan Migneault (new window) · CBC News


Canada Standard
21 hours ago
- Canada Standard
Q&A: How Deep Energy Retrofits Can Unlock Health Care Savings in Alberta
Across Canada, provinces like British Columbia, Quebec, Nova Scotia, and Ontario are investing in energy retrofits to cut emissions, lower energy bills, and improve health. But Alberta stands apart-not for what it's doing, but for what it isn't. There, 42% of 598,000 homes built before 1980 need repairs and upgrades. But Alberta is the only province or territory that doesn't allow utilities to engage in demand-side management (DSM) programs-initiatives that help people use less energy by funding things like insulation, heat pumps, and efficient appliances. Amid increasing wildfire smoke, extreme heat, and rising energy prices, retrofit advocates are working to build institutional support for programs to make homes safer for Albertans. Though retrofits can be costly and complex, a new Pembina Institute report shows their full value emerges when health care savings are factored into the equation. For example, researchers in England found that poor housing conditions cost their country's health care system $3 billion each year. Simply fixing homes that were too cold would save the National Health Service $1.8 billion per year in avoided costs, the study found. In New Zealand, researchers uncovered remarkable health and energy savings from retrofits made during a multi-year insulation and clean heating program, writes Pembina. After tracking hospitalization rates, prescription costs, and mortality across retrofitted and non-retrofitted homes, they found that insulation had the most benefit, while the biggest health savings came from reduced mortality. The program had a net return of $1.03 billion in health and energy savings-for every dollar spent, four dollars were returned. The Energy Mix talked with report author Raidin Blue, an analyst with the Pembina Institute's buildings program, about Alberta's retrofit gap, its health and equity impacts, and what's needed to drive policy change. The Mix : Why is it important to highlight both health and energy savings when making the case for deep retrofits? View our latest digests Retrofits aren't just about energy-they have a broader value proposition that we aren't capturing. We believe deep retrofits can be key to making life more affordable for Canadians, which is a huge priority right now. The business case for deep retrofits needs to be expanded to include non-energy benefits: improved health and safety, enhanced resilience, and better insurance coverage. When all of that is factored in, deep retrofits make strong financial sense. The Mix : Who do you hope will act on this report-and what message do you want them to walk away with? Building owners. I want them to understand that health is tied to housing-we spend 90% of our lives indoors. Poor ventilation? Air quality issues can damage your lungs. Struggling to keep your home warm in winter? Chronic cold is linked to cardiovascular issues. Both owners and tenants can face serious health impacts from their buildings, and retrofits are a powerful solution. The Mix: You highlight vulnerable households-like low-income families and seniors-living in poor-quality housing, yet Alberta has no province-wide retrofit strategy. However, we are seeing targeted programs like the Metis Government's federally funded $9.24-million retrofit initiative. What would it take to build broader political or institutional support for retrofits in Alberta? And should the feds step up with funding? People in Alberta want to retrofit. The demand is there. It is great to see this initiative from the Metis Government. The City of Calgary also expanded its Home Upgrades Program, and 20-some communities are involved in Alberta Municipalities' Clean Energy Improvement Program (CEIP). Unfortunately, CEIP programs are often out of reach for vulnerable populations, since the funding is tied to property taxes-and many low-income families and seniors don't own their homes. In provinces and territories where there are utility-led Demand-Side Management (DSM) programs, retrofit initiatives are common, and many focus specifically on low-income housing. These programs offer stable, year-over-year funding that building owners can rely on. So a key first step would be for Alberta-a DSM outlier in Canada-to enable utilities to administer and invest in them. At the federal level, the Canada Greener Homes Affordability Program has allocated C$800 to $900 million across the country to support retrofits in low- to median-income homes. So far, Alberta is the only province not actively working to access those funds. In most other jurisdictions, they're managed through a combination of designated agencies and utilities. To advance deep retrofits in Alberta and across Canada, all levels of government need to work more closely with important players like Natural Resources Canada, Infrastructure Canada, Canada Mortgage and Housing Corporation, insurance companies, and health authorities. We need to better understand the impacts of retrofits on everything from health to resilience to affordability-and then create stable supports and incentives. That's when building owners will begin to see real returns on deep retrofit investments-beyond just utility bill savings and emissions reductions. The Mix : You've drawn on international examples from Australia, New Zealand, and the United States. Are conditions in Alberta different enough that more local research is still needed? Where should that work start? It is great to see that Australia saved senior households $840 a winter-I think a health-focused retrofit study in Alberta would see significant health savings. We had hesitations with extrapolations because our examples vary from Alberta in both climate and by types of buildings-so we tried not to make direct comparisons. Alberta-specific pilots would showcase the health benefits of retrofits to building owners, local and provincial governments, and the retrofit industry as a whole. Fortunately, these benefits are likely to emerge even without extensive data collection or formal studies. A good starting point could be post-retrofit surveys, where program managers ask tenants about increased comfort or improvements in their overall health and well-being. From there, deeper research could explore reductions in sick days or asthma symptoms. This means working with health care providers to make stronger links between retrofits, health outcomes, and avoided health care costs. The Mix: Are there any promising examples in Canada-provincial or local-where health research is already influencing retrofit policy or program design? Canadians are really starting to make this connection between our built environment and health. For years people have discussed active transportation, walkable cities, and their health benefits. The University of Alberta has a Climate Change + Health Hub and the Housing for Health initiative because these are important issues to Albertans. Look to the 2021 heat dome, when 619 people died in British Columbia, 66 in Alberta. The B.C. government responded with a formal coroner's investigation and the province worked with utility BC Hydro to provide free air conditioners to vulnerable people. Similar programs were also launched in Oregon and Washington State. These are promising, but still just responses to acute events-they don't take a whole-building approach to deep retrofits. I want policy-makers and researchers to understand that-beyond heat waves-there are chronic health impacts associated with our housing. The Mix : What makes you optimistic that this framing will gain traction? Are decision-makers starting to think differently about the value of deep retrofits? Retrofits do make a difference and that gives me optimism. They are the one form of climate policy that does both climate mitigation and adaptation. They can make our homes healthier, safer, and more affordable. Part of our work over the next year will be to bring together all of these pieces for a complete deep retrofit business case. We just need coordinated efforts from all orders of government, utilities, insurance and investment sectors, and building owners, to keep Canadians healthy and safe. Source: The Energy Mix